Hospital Acquired Infections Market Size, Share, and Trends 2026 to 2035

Hospital Acquired Infections Market Size and Growth 2026 to 2035

The global hospital acquired infections market size was valued at USD 31.52 billion in 2025 and is projected to grow from USD 31.97 billion in 2026 to USD 36.36 billion by 2035, at a CAGR of 1.44% from 2026 to 2035. North America dominated the market, accounting for a revenue share of 39.0% in 2025.

Key Takeaway

• By type, the consumables segment dominated the market with the largest share in 2025.
• By type, the service segment is expected to grow at the fastest CAGR over the forecast period.
• By end user, the hospitals segment dominated the market with the largest share of 56.0% in 2025.
• By region, North America dominated the market with the largest share of 39.0% in 2025.

Market Overview

Hospital-acquired infections (HAIs), also known as healthcare-associated infections, continue to pose a major challenge to healthcare systems worldwide. These infections occur during medical treatment and include surgical site infections, bloodstream infections, urinary tract infections, ventilator-associated pneumonia, and infections caused by antibiotic-resistant pathogens. HAIs increase patient complications, extend hospital stays, and raise healthcare costs.

The growing emphasis on patient safety and stricter infection control regulations is driving demand for advanced sterilization equipment, disinfectants, disposable medical supplies, and infection prevention solutions. Rising surgical procedures, an aging population, and the increasing burden of chronic diseases are further supporting market growth. In addition, healthcare providers are adopting automated sterilization systems, UV disinfection technologies, hydrogen peroxide vapor sterilizers, and AI-powered infection surveillance to improve clinical outcomes. The shift toward sustainable, energy-efficient, and cost-effective sterilization technologies is also accelerating innovation, supporting the long-term expansion of the hospital acquired infections market.

Market Outlook

• Market Growth Overview: The global hospital acquired infections market is expected to grow significantly between 2025 and 2035, driven by increasing surgical procedure rates across the globe.
• Sustainability Trends: Sustainability trends involve a strategic transition towards sustainable disinfectants and adoption of energy-efficient sterilization equipment.
• Major Investors: Major investors in the market include 3M, STERIS plc, Getinge AB, Ecolab Inc., and Becton, Dickinson and Company (BD).

How AI is Impacting the Global Hospital Acquired Infections Market?

Artificial intelligence is transforming hospital infection prevention by enabling real-time surveillance, predictive risk assessment, and automated clinical decision-making. AI-powered platforms analyze electronic health records, laboratory reports, microbiology data, pharmacy records, and patient movement to detect infection patterns earlier than traditional monitoring methods. Predictive analytics helps identify high-risk patients, allowing healthcare providers to implement preventive measures before infections develop. AI also strengthens antimicrobial stewardship by optimizing antibiotic selection and treatment duration, reducing unnecessary antibiotic use and limiting antimicrobial resistance. In addition, computer vision monitors hand hygiene and PPE compliance, while natural language processing extracts infection-related insights from clinical documentation, improving surveillance accuracy and reducing administrative workload. As AI integrates with cloud-based hospital systems, infection prevention is shifting from reactive outbreak control to proactive healthcare quality management.

Hospital Acquired Infections Market Report Scope

Market Driver

Rising Surgical Procedures and Hospital Admissions Fuel Market Growth

The increasing number of hospital admissions and complex surgical procedures is a key driver of the hospital acquired infections market. Aging populations, growing chronic disease prevalence, trauma cases, organ transplants, cancer treatments, and cardiovascular and orthopedic surgeries have expanded the number of patients at risk of healthcare-associated infections. The widespread use of invasive medical devices such as catheters, ventilators, implants, and dialysis equipment further increases infection risks. To improve patient safety, hospitals are investing in advanced sterilization systems, automated washer-disinfectors, high-level disinfectants, disposable medical products, and infection surveillance technologies. The expansion of centralized sterile processing departments equipped with automated sterilizers and low-temperature sterilization systems continues to support market growth.

Market Restraint

High Cost of Advanced Infection Prevention Technologies

The high cost of modern sterilization and infection control technologies remains a major challenge for market growth. Advanced sterilization equipment, robotic disinfection systems, automated endoscope reprocessors, and AI-based surveillance platforms require significant capital investment, ongoing maintenance, software upgrades, and staff training. Many community hospitals and healthcare facilities in developing regions face budget constraints that delay infrastructure modernization. As a result, numerous institutions continue relying on conventional sterilization methods, leading to slower adoption of advanced infection prevention solutions despite increasing awareness of patient safety.

Market Opportunity

Digital Infection Prevention Solutions Create New Growth Opportunities

The rapid digitalization of healthcare systems is creating significant opportunities in the hospital acquired infections market. Healthcare providers are increasingly adopting integrated infection management platforms that combine microbiology results, laboratory information, pharmacy data, sterilization records, environmental monitoring, and patient health information into centralized dashboards. Cloud-based surveillance systems enable real-time outbreak detection, automated regulatory reporting, antimicrobial resistance monitoring, and compliance tracking. Furthermore, the integration of AI, IoT-enabled sterilization devices, wearable sensors, and predictive analytics is improving operational efficiency and infection control outcomes. Growing investments in digital hospital infrastructure across emerging economies are expected to generate strong opportunities for software providers, sterilization equipment manufacturers, and infection prevention solution companies.

Segmental Insights

By Type

Why did the consumables segment dominate the global hospital acquired infections market?

The consumables segment dominated the market with the largest share in 2025. The dominance of the segment can be attributed to the increasing volume of surgical procedures and stringent government hygiene regulations. In addition; to reduce cross-contamination risks, healthcare facilities are strictly prioritizing single-use medical nonwovens and devices over reprocessed alternatives.

How did the service segment expected to hold the significantly growing global hospital acquired infections market in the coming years?

The service segment is expected to grow at the fastest CAGR over the forecast period. The growth of the segment can be credited to the increasing need for outsourced contract sterilization and adoption of innovative real-time infection tracking software. The growing volume of both inpatient and outpatient procedures increases the demand for systematic, professional decontamination services.

By End User

Why did the hospitals segment dominate the global hospital acquired infections market?

The hospitals segment dominated the market with the largest share in 2025. The dominance of the segment can be linked to the growing pattern of admissions and rapid increase in surgical procedures across the globe. Also, the proliferation of drug-resistant superbugs necessitates substantial capital expenditure by healthcare facilities toward advanced sterilization technologies, diagnostic systems, and rigorous hygiene protocols.

How did the ambulatory surgical centers (ASCs) segment expected to hold the significantly growing global hospital acquired infections market in the coming years?

The ambulatory surgical centers (ASCs) segment is expected to grow at the fastest CAGR over the forecast period. The growth of the segment can be driven by an ongoing transition towards outpatient care and surged adoption of single-use disposable medical devices. Furthermore, manufacturers are now designing specialized, custom-made infection control solutions precisely tailored to outpatient and ambulatory clinical workflows.

By Regional

Why did the North American region account for the largest share in the global hospital acquired infections market?

North America dominated the market with the largest share in 2025. The dominance of the region can be attributed to the growing prevalence of nosocomial pathogens and the surge in investments in cutting-edge hospital hygiene management. In addition, the rising prevalence of drug-resistant pathogens, including Candida auris and other multi-drug-resistant organisms, needs ongoing surveillance and the reinforcement of infection control protocols.

U.S. Global Hospital Acquired Infections Market Trends

The growth of the market in the country can be driven by the growing investments in cutting-edge disinfection tech and surge in elderly population. Also, substantial infrastructure funding enables healthcare facilities within the United States to systematically increase clinical hygiene protocols and integrate sophisticated diagnostic technologies.

Why did the Asia-Pacific region become the fastest-growing global hospital acquired infections market during the forecast period?

Asia Pacific is expected to grow at the fastest CAGR over the forecast period. The growth of the region can be credited to the surge in healthcare infrastructure growth and increasing geriatric populations in emerging economies. Furthermore, stricter hygiene standards, public health initiatives, and enhanced collaborative funding are compelling clinics to implement single-use supplies and automated sterilization technology, leading to regional growth soon.

China Global Hospital Acquired Infections Market Trends

The market in the country is growing due to stringent regulatory standards, a surge in the aging population, and infrastructure modernization initiatives. Moreover, the growing volume of complex inpatient procedures inherently increases baseline infection risks, hence accelerating the demand for safety consumables and advanced infection control solutions.

Key Players in the Global Hospital Acquired Infections Market

• 3M Company: It provides comprehensive medical tapes, skin preps, and sterilization monitoring indicators.
• Becton, Dickinson and Company (BD): It offers safety-engineered medical devices and medication management systems to reduce contamination.
• Advanced Sterilization Products (ASP): Known for low-temperature hydrogen peroxide sterilization technologies used for delicate surgical instruments.

Recent Developments

• In May 2026, Seegene expanded its infectious disease testing portfolio in Europe by introducing a new molecular diagnostic assay for multidrug-resistant organisms (MDROs). This strategic launch addresses the increasing pressure on healthcare facilities to enhance infection prevention protocols and strengthen antimicrobial resistance (AMR) monitoring.

Segments Covered in the Report

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2035. For this study, Nova one advisor, Inc. has hospital acquired infections market.

By Type

• Equipment
• Sterilization Equipment
  
  • Heat Sterilization Equipment
  • Low Temperature Sterilization
  • Radiation Sterilization
• Disinfection Equipment
  
  • Washer Disinfector
  • Flusher Disinfector
  • Endoscopic Reprocessor Systems
• Services
• Consumables
• Disinfectants
• Sterilization Consumables

By End-user

• Hospitals
• Specialty Clinics
• Diagnostic Centers
• Ambulatory Surgical Centers (ASCs)
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa